References
- Chhabra N, Rizvanolli L, Rasin A, Marsden G, Hinami K, Aks SE. A cross-sectional analysis of fentanyl analog exposures among living patients. Am J Drug Alcohol Abuse. 2021;1–6. doi:https://doi.org/10.1080/00952990.2021.1891420.
- Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70:202–07. doi:https://doi.org/10.15585/mmwr.mm7006a4.
- Delcher C, Wang Y, Vega RS, Halpin J, Gladden RM, O’Donnell JK, Hvozdovich JA, Goldberger BA. Carfentanil outbreak - Florida, 2016–2017. MMWR Morb Mortal Wkly Rep. 2020;69:125–29.
- Tuzel T, Bollini SM, Antara JP, Banks JF, Hobbs GA. Carfentanil use in a patient undergoing treatment for substance use disorder. J Anal Toxicol. 2020;44:618–22. doi:https://doi.org/10.1093/jat/bkaa011.
- Baldwin GT, Seth P, Noonan RK. Continued increases in overdose deaths related to synthetic opioids: implications for clinical practice. JAMA. 2021;325:1151–52. doi:https://doi.org/10.1001/jama.2021.1169.
- Wharton RE, Casbohm J, Hoffmaster R, Brewer BN, Finn MG, Johnson RC. Detection of 30 fentanyl analogs by commercial immunoassay kits. J Anal Toxicol. 2021;45:111–16. doi:https://doi.org/10.1093/jat/bkaa181.